Processa Pharmaceuticals, Inc. (PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have high unmet medical need conditions, announced today the last patient has been enrolled in the...
Oncoceutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug (IND) application for ONC206, allowing the first-in-human trial of the compound. ONC206 is the first of the family of drug candidates,...
Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced today that the U.S. District Court of Delaware has set a trial date for Lipocine’s patent infringement lawsuit against Clarus’s...
– Trial leads to discovery that onvansertib stops rise in PSA in patients with treatment-resistant, highly-aggressive and difficult-to-treat androgen-receptor variant 7 (AR-V7) tumors – Data demonstrates efficacy of onvansertib in patients showing early...
Washington D.C. [USA], Aug 26 (ANI): Pomegranate juice which is known to be rich with nutrients can help in developing brains of infants, according to a study. When it comes to protecting the newborn brain, taking steps to mitigate risk before birth may be critical....
Processa Pharmaceuticals, Inc. (PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have high unmet medical need conditions, announced today the last patient has been enrolled in the...
Email
Text